Does a high genomic risk score impact your radiation fields for patients with breast cancer?

For example, would a high Oncotype warrant treating with RNI in a patient who would otherwise be treated with high tangents?

Answer from: Radiation Oncologist at Community Practice

For SNLN node positive pts if high genomic score favor RNI instead of high tangent